These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 9591537
1. Regulators of proliferation and apoptosis in carcinoma of the larynx. Whisler LC, Wood NB, Caldarelli DD, Hutchinson JC, Panje WR, Friedman M, Preisler HD, Leurgans S, Nowak J, Coon JS. Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537 [Abstract] [Full Text] [Related]
2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M. J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [Abstract] [Full Text] [Related]
3. [The expression and significance of bcl-2 and bax in each phase of the cell cycle in laryngeal carcinoma]. Chen WL, Guo XF, Quan CS, Luan XY. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):157-61. PubMed ID: 15283295 [Abstract] [Full Text] [Related]
4. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L. Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137 [Abstract] [Full Text] [Related]
5. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Georgiou A, Gomatos IP, Ferekidis E, Syrigos K, Bistola V, Giotakis J, Adamopoulos G, Androulakis G. Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092 [Abstract] [Full Text] [Related]
6. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC, Betticher DC. Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896 [Abstract] [Full Text] [Related]
7. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma]. Guan W, Yu S, Gao Y. Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367 [Abstract] [Full Text] [Related]
8. Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium. Drenning SD, Marcovitch AJ, Johnson DE, Melhem MF, Tweardy DJ, Grandis JR. Clin Cancer Res; 1998 Nov; 4(11):2913-21. PubMed ID: 9829760 [Abstract] [Full Text] [Related]
9. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Jäckel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W. Cancer; 1999 Feb 01; 85(3):591-9. PubMed ID: 10091732 [Abstract] [Full Text] [Related]
10. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma. Allal AS, Waelchli L, Bründler MA. Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153 [Abstract] [Full Text] [Related]
11. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Crowe DL, Sinha UK. Head Neck; 2006 Jan 15; 28(1):15-23. PubMed ID: 16302195 [Abstract] [Full Text] [Related]
12. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas. Fracchiolla NS, Capaccio P, Carboni N, Pagliari AV, Neri A, Ronchett D, Pruner G, Silvotti MG, Pignataro L, Buffa R, Broich G. Anticancer Res; 1999 Jan 15; 19(2A):1043-51. PubMed ID: 10368653 [Abstract] [Full Text] [Related]
13. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck. Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E. Anticancer Res; 1998 Jan 15; 18(6B):4741-9. PubMed ID: 9891551 [Abstract] [Full Text] [Related]
14. Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas. Xie X, Clausen OP, Boysen M. Laryngoscope; 2004 Oct 15; 114(10):1785-90. PubMed ID: 15454773 [Abstract] [Full Text] [Related]
15. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Cancer Res; 1996 May 15; 56(10):2422-7. PubMed ID: 8625322 [Abstract] [Full Text] [Related]
16. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Torzewski M, Sarbia M, Heep H, Dutkowski P, Willers R, Gabbert HE. Clin Cancer Res; 1998 Mar 15; 4(3):577-83. PubMed ID: 9533524 [Abstract] [Full Text] [Related]
17. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G, Antonaci A, Bosco D, Nardoni S, Melis M. J Exp Clin Cancer Res; 1999 Sep 15; 18(3):363-7. PubMed ID: 10606183 [Abstract] [Full Text] [Related]
18. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. Sarbia M, Stahl M, Fink U, Willers R, Seeber S, Gabbert HE. Clin Cancer Res; 1998 Dec 15; 4(12):2991-7. PubMed ID: 9865911 [Abstract] [Full Text] [Related]
19. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. Laryngoscope; 2002 Apr 15; 112(4):638-44. PubMed ID: 12150516 [Abstract] [Full Text] [Related]
20. Prognostic value of Bak expression in oral tongue squamous cell carcinomas. Xie X, Clausen OP, Boysen M. Oncol Rep; 2003 Apr 15; 10(2):369-74. PubMed ID: 12579274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]